PRETARG-IT Trademark
PRETARG-IT is a USPTO trademark filed by OncoOne Research & Development GmbH. Status: Registered.
Trademark Facts
| Mark | PRETARG-IT |
|---|---|
| Serial Number | 79345233 |
| Registration Number | 7095573 |
| Status | Registered |
| Filing Date | 2022-05-25 |
| Registration Date | 2023-07-04 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 042 (Software & IT), 044 (Medical Services) |
| Owner | OncoOne Research & Development GmbH |
| Prosecution Events | 16 |
| Latest Event | NREP on 2025-11-21 |
Goods & Services
Pharmaceuticals and veterinary preparations, namely, pharmaceutical preparations comprising antibodies for the treatment and prevention of diseases, namely, hyperproliferative and inflammatory diseases; pharmaceuticals and veterinary preparations, namely, pharmaceutical preparations comprising antigen binding fragments for the treatment and prevention of diseases, namely, hyperproliferative and inflammatory diseases; preparations for medical and veterinary purposes comprising antibodies for the treatment and prevention of diseases, namely, hyperproliferative and inflammatory diseases; preparations for medical and veterinary purposes comprising antigen binding fragments for the treatment and prevention of diseases, namely, hyperproliferative and inflammatory diseases | Scientific and technological services, namely, scientific research in the field of diseases using antibodies; scientific and technological services, namely, scientific research in the field of diseases using antibodies and antigen binding fragments thereof; industrial analysis and research services in the field of diseases using antibodies; industrial analysis and research services in the field of diseases using antigen binding fragments thereof, and medical research services; pharmaceutical and biotechnological research and development; biotechnological research services | Medical and veterinary services, namely, services for the treatment and prevention of diseases using antibodies; medical and veterinary services, namely, services for the treatment and prevention of diseases using antigen binding fragments thereof